Bernie fights in California. Photo by L.A. Times
If you’re feeling bereft, take note: Bernie Sanders is still here loudly fighting the good fight, this week blasting the avarice of Big Pharma so persuasively he sent their stock prices plunging to a seven-month low. After battling Big Pharma for decades – pillorying the makers of the emergency allergy injection EpiPen for obscenely jacking up their prices, recently calling out another company’s price hikes on leukemia drugs, and campaigningthis fall to stop price-gouging by helping pass California’s Proposition 61, seen by many as Ground Zero for drug companies and their 1,266 D.C. lobbyists – Bernie isn’t letting up.
In a Tuesday Tweetstorm, he accused Eli Lilly and Novo Nordisk of ripping off diabetes patients by wildly inflating the price of their life-saving insulin drug Homolog, whose price has soared from $21 to $255. Posting telling details and graphics from a Washington Poststory on the rise of insulin prices along with a hard-hitting video, Sanders charged, “Eli Lilly and Novo Nordisk clearly care more about their profits than their patients. It’s time to end their greed.” Following his charge, stock prices for Eli Lilly promptly dropped 2.4%, a seven-month low. When the company tried defending itself with a vague statement that “the answer itself isn’t simple,” a still-pissed, plain-speaking Bernie shot back that, actually, it is. “Why has the (price) gone up 700% in 20 years?” he asked. “The drug industry’s greed.”
[THIS IS POSTED HERE FOR NON-PROFIT, NON-COMMERCIAL, EDUCATIONAL PURPOSE]